Skip to main content
. 2018 Oct 26;2018(10):CD007554. doi: 10.1002/14651858.CD007554.pub3

NCT01228279.

Trial name or title Sympathetic Activity in Patients With End‐stage Renal Disease on Peritoneal Dialysis (SAPD)
Methods

  • Study design: parallel

  • Randomisation method: not reported

  • Blinding: open label, single blind (outcome assessor)

  • Intention to treat: unclear

  • Follow‐up period: 18 weeks
Participants

  • Countries: Canada

  • Setting: single centre

  • Incident CAPD and CCPD patients
Interventions

  • Icodextrin for the night‐time exchange for a period of 12 weeks ( 7 to 18 week of study)
Outcomes

  • muscle sympathetic nerve activity

  • change in extracellular volume

  • BP

  • RRF
Starting date

  • July 2017
Contact information Marcel Ruzicka, MD, mruzicka@ottawahospital.on.ca
Notes  

BP ‐ blood pressure; CAPD ‐ continuous ambulatory peritoneal dialysis; CCPD ‐ continuous cycling peritoneal dialysis; RRF ‐ residual renal function